- Home
- GDYN vs KURA Comparison
GDYN vs KURA Comparison
Compare GDYN & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GDYN
- KURA
- Stock Information
- Founded
- GDYN 2006
- KURA 2014
- Country
- GDYN United States
- KURA United States
- Employees
- GDYN N/A
- KURA N/A
- Industry
- GDYN Computer Software: Prepackaged Software
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GDYN Technology
- KURA Health Care
- Exchange
- GDYN Nasdaq
- KURA Nasdaq
- Market Cap
- GDYN 1.1B
- KURA 561.9M
- IPO Year
- GDYN N/A
- KURA N/A
- Fundamental
- Price
- GDYN $10.38
- KURA $6.13
- Analyst Decision
- GDYN Strong Buy
- KURA Strong Buy
- Analyst Count
- GDYN 4
- KURA 12
- Target Price
- GDYN $18.75
- KURA $24.50
- AVG Volume (30 Days)
- GDYN 753.0K
- KURA 1.4M
- Earning Date
- GDYN 07-31-2025
- KURA 08-07-2025
- Dividend Yield
- GDYN N/A
- KURA N/A
- EPS Growth
- GDYN 322.00
- KURA N/A
- EPS
- GDYN 0.13
- KURA N/A
- Revenue
- GDYN $371,169,000.00
- KURA $67,991,000.00
- Revenue This Year
- GDYN $21.02
- KURA $125.04
- Revenue Next Year
- GDYN $13.95
- KURA $83.75
- P/E Ratio
- GDYN $81.93
- KURA N/A
- Revenue Growth
- GDYN 18.72
- KURA N/A
- 52 Week Low
- GDYN $10.26
- KURA $5.41
- 52 Week High
- GDYN $25.50
- KURA $23.48
- Technical
- Relative Strength Index (RSI)
- GDYN 28.13
- KURA 51.23
- Support Level
- GDYN $10.35
- KURA $5.65
- Resistance Level
- GDYN $12.86
- KURA $6.51
- Average True Range (ATR)
- GDYN 0.52
- KURA 0.27
- MACD
- GDYN -0.10
- KURA 0.06
- Stochastic Oscillator
- GDYN 4.78
- KURA 59.68
About GDYN Grid Dynamics Holdings Inc.
Grid Dynamics Holdings Inc is a provider of technology consulting, platform and product engineering, and advanced analytics services. The company delivers tailored solutions in several industry verticals like Tech, Media and Telecom, Retail, Finance and Consumer Packaged goods (CPG)/manufacturing. The company derives maximum revenue from Retails. Geographically company earns revenue from North America, Europe and other regions.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.